首页> 外文期刊>Applied psychophysiology and biofeedback >Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression
【24h】

Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression

机译:开放式研究心率变异性生物反馈治疗重度抑郁症的初步结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Major depressive disorder (MDD) is a common mood disorder that can result in significant discomfort as well as interpersonal and functional disability. A growing body of research indicates that autonomic function is altered in depression, as evidenced by impaired baroreflex sensitivity, changes in heart rate, and reduced heart rate variability (HRV). Decreased vagal activity and increased sympathetic arousal have been proposed as major contributors to the increased risk of cardiovascular mortality in participants with MDD, and baroreflex gain is decreased. Study objectives: To assess the feasibility of using HRV biofeedback to treat major depression. Design: This was an open-label study in which all eleven participants received the treatment condition. Participants attended 10 weekly sessions. Questionnaires and physiological data were collected in an orientation (baseline) session and Treatment Sessions 1, 4, 7 and 10. Measurements and results: Significant improvements were noted in the Hamilton Depression Scale (HAM-D) and the Beck Depression Inventory (BDI-II) by Session 4, with concurrent increases in SDNN, standard deviation of normal cardiac in-terbeat intervals) an electrocardiographic estimate of overall measure of adaptability. SDNN decreased to baseline levels at the end of treatment and at follow-up, but clinically and statistically significant improvement in depression persisted. Main effects for task and session occurred for low frequency range (LF) and SDNN. Increases in these variables also occurred during breathing at one's resonant frequency, which targets baroreflex function and vagus nerve activity, showing that subjects performed the task correctly Conclusions: HRV biofeedback appears to be a useful adjunctive treatment for the treatment of MDD, associated with large acute increases in HRV and some chronic increases, suggesting increased cardiovagal activity. It is possible that regular exercise of homeostatic reflexes helps depression even when changes in baseline HRV are smaller. A randomized controlled trial is warranted.
机译:重度抑郁症(MDD)是一种常见的情绪障碍,可导致严重的不适以及人际关系和功能障碍。越来越多的研究表明,抑郁症中的自主神经功能发生了改变,这表现为压力感受器反射敏感性降低,心率变化和心率变异性(HRV)降低。迷走神经活动的减少和交感唤醒的增加被认为是导致MDD参与者心血管死亡风险增加的主要因素,而压力反射反射的获得则下降。研究目标:评估使用HRV生物反馈治疗严重抑郁症的可行性。设计:这是一项开放标签研究,所有11名参与者均接受了治疗。参加者每周参加10次会议。问卷调查和生理数据是在定向(基线)环节和治疗环节1、4、7和10中收集的。测量和结果:汉密尔顿抑郁量表(HAM-D)和贝克抑郁量表(BDI- II)在第4课之前,同时增加SDNN,正常心脏心跳间隔的标准偏差)心电图评估整体适应性。在治疗结束时和随访时,SDNN降至基线水平,但抑郁症的临床和统计学显着改善仍然持续。任务和会话的主要影响发生在低频范围(LF)和SDNN。这些变量的增加也出现在呼吸过程中,其共振频率以压力反射功能和迷走神经活动为目标,表明受试者正确完成了任务。结论:HRV生物反馈似乎是治疗MDD的有效辅助治疗,与大急性HRV升高,并有一些慢性升高,提示心血管活动增加。即使基线HRV的变化较小,定期进行体内反射也有可能帮助抑郁症。随机对照试验是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号